These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 17936557)

  • 21. Loss of TGF-β responsiveness in prostate stromal cells alters chemokine levels and facilitates the development of mixed osteoblastic/osteolytic bone lesions.
    Li X; Sterling JA; Fan KH; Vessella RL; Shyr Y; Hayward SW; Matrisian LM; Bhowmick NA
    Mol Cancer Res; 2012 Apr; 10(4):494-503. PubMed ID: 22290877
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TβRII Regulates the Proliferation of Metanephric Mesenchyme Cells through Six2 In Vitro.
    Mao Z; Lyu Z; Huang L; Zhou Q; Weng Y
    Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28420207
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic ablation of alphav integrins in epithelial cells of the eyelid skin and conjunctiva leads to squamous cell carcinoma.
    McCarty JH; Barry M; Crowley D; Bronson RT; Lacy-Hulbert A; Hynes RO
    Am J Pathol; 2008 Jun; 172(6):1740-7. PubMed ID: 18467691
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TGF-beta receptor II in epithelia versus mesenchyme plays distinct roles in the developing lung.
    Chen H; Zhuang F; Liu YH; Xu B; Del Moral P; Deng W; Chai Y; Kolb M; Gauldie J; Warburton D; Moses HL; Shi W
    Eur Respir J; 2008 Aug; 32(2):285-95. PubMed ID: 18321928
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SPSB1, a Novel Negative Regulator of the Transforming Growth Factor-β Signaling Pathway Targeting the Type II Receptor.
    Liu S; Nheu T; Luwor R; Nicholson SE; Zhu HJ
    J Biol Chem; 2015 Jul; 290(29):17894-17908. PubMed ID: 26032413
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A "traffic control" role for TGFbeta3: orchestrating dermal and epidermal cell motility during wound healing.
    Bandyopadhyay B; Fan J; Guan S; Li Y; Chen M; Woodley DT; Li W
    J Cell Biol; 2006 Mar; 172(7):1093-105. PubMed ID: 16549496
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prostate cancer induced by loss of Apc is restrained by TGFβ signaling.
    Bjerke GA; Pietrzak K; Melhuish TA; Frierson HF; Paschal BM; Wotton D
    PLoS One; 2014; 9(3):e92800. PubMed ID: 24651496
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transforming Growth Factor-β Promotes Liver Tumorigenesis in Mice via Up-regulation of Snail.
    Moon H; Ju HL; Chung SI; Cho KJ; Eun JW; Nam SW; Han KH; Calvisi DF; Ro SW
    Gastroenterology; 2017 Nov; 153(5):1378-1391.e6. PubMed ID: 28734833
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Deficiency for the cysteine protease cathepsin L promotes tumor progression in mouse epidermis.
    Dennemärker J; Lohmüller T; Mayerle J; Tacke M; Lerch MM; Coussens LM; Peters C; Reinheckel T
    Oncogene; 2010 Mar; 29(11):1611-21. PubMed ID: 20023699
    [TBL] [Abstract][Full Text] [Related]  

  • 30. De-ubiquitinating enzyme, USP11, promotes transforming growth factor β-1 signaling through stabilization of transforming growth factor β receptor II.
    Jacko AM; Nan L; Li S; Tan J; Zhao J; Kass DJ; Zhao Y
    Cell Death Dis; 2016 Nov; 7(11):e2474. PubMed ID: 27853171
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transforming growth factor-beta1 promotes invasiveness after cellular transformation with activated Ras in intestinal epithelial cells.
    Fujimoto K; Sheng H; Shao J; Beauchamp RD
    Exp Cell Res; 2001 Jun; 266(2):239-49. PubMed ID: 11399052
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1.
    Subramanian G; Schwarz RE; Higgins L; McEnroe G; Chakravarty S; Dugar S; Reiss M
    Cancer Res; 2004 Aug; 64(15):5200-11. PubMed ID: 15289325
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Non-hematopoietic PAR-2 is essential for matriptase-driven pre-malignant progression and potentiation of ras-mediated squamous cell carcinogenesis.
    Sales KU; Friis S; Konkel JE; Godiksen S; Hatakeyama M; Hansen KK; Rogatto SR; Szabo R; Vogel LK; Chen W; Gutkind JS; Bugge TH
    Oncogene; 2015 Jan; 34(3):346-56. PubMed ID: 24469043
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Coordinated functions of E-cadherin and transforming growth factor beta receptor II in vitro and in vivo.
    Andl CD; Fargnoli BB; Okawa T; Bowser M; Takaoka M; Nakagawa H; Klein-Szanto A; Hua X; Herlyn M; Rustgi AK
    Cancer Res; 2006 Oct; 66(20):9878-85. PubMed ID: 17047049
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TGFβ loss activates ADAMTS-1-mediated EGF-dependent invasion in a model of esophageal cell invasion.
    Le Bras GF; Taylor C; Koumangoye RB; Revetta F; Loomans HA; Andl CD
    Exp Cell Res; 2015 Jan; 330(1):29-42. PubMed ID: 25064463
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Loss of Rab25 promotes the development of skin squamous cell carcinoma through the dysregulation of integrin trafficking.
    Jeong H; Lim KM; Kim KH; Cho Y; Lee B; Knowles BC; Roland JT; Zwerner JP; Goldenring JR; Nam KT
    J Pathol; 2019 Oct; 249(2):227-240. PubMed ID: 31144312
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Androgenic control of transforming growth factor-beta signaling in prostate epithelial cells through transcriptional suppression of transforming growth factor-beta receptor II.
    Song K; Wang H; Krebs TL; Kim SJ; Danielpour D
    Cancer Res; 2008 Oct; 68(19):8173-82. PubMed ID: 18829577
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A dominant inhibitory mutant of the type II transforming growth factor beta receptor in the malignant progression of a cutaneous T-cell lymphoma.
    Knaus PI; Lindemann D; DeCoteau JF; Perlman R; Yankelev H; Hille M; Kadin ME; Lodish HF
    Mol Cell Biol; 1996 Jul; 16(7):3480-9. PubMed ID: 8668164
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Smad7 but not Smad6 cooperates with oncogenic ras to cause malignant conversion in a mouse model for squamous cell carcinoma.
    Liu X; Lee J; Cooley M; Bhogte E; Hartley S; Glick A
    Cancer Res; 2003 Nov; 63(22):7760-8. PubMed ID: 14633701
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assembly of TbetaRI:TbetaRII:TGFbeta ternary complex in vitro with receptor extracellular domains is cooperative and isoform-dependent.
    Zúñiga JE; Groppe JC; Cui Y; Hinck CS; Contreras-Shannon V; Pakhomova ON; Yang J; Tang Y; Mendoza V; López-Casillas F; Sun L; Hinck AP
    J Mol Biol; 2005 Dec; 354(5):1052-68. PubMed ID: 16289576
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.